Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 78.2/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 23.5; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 78.1/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 75.7; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 78.1/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 53.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 78.0/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 30.1; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 78.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 30.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.9/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 29.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.9/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 84.4; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.8/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 68.8; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 76.2; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 58.2; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 48.2; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 48.2; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 28.1; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 53.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 35.5; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 95.3; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.5/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 50.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.5/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 20.0; sample size: 100.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.3/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 34.0; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 77.3/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 46.3; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
